
UPEXI INC
UPXINASDAQTrading Snapshot
- Day Range
- $0.80 β $0.82
- 52-Week Range
- $0.54 β $9.12
- Volume
- $2.01B
- Avg Volume
- $2.10B
- Shares Outstanding
- 73.5M
- Next Earnings
- Sep 10, 2026
Fundamentals Snapshot
- Annual Revenue
- $16M
- Last Q Revenue
- $5M
- P/E Ratio
- -0.2
- P/S Ratio
- 2.3x
- EPS (TTM)
- $-3.49
- Dividend Yield
- 0.00%
Why Investors Own UPXI
- βHigh-growth profile β revenue up +47.1% YoY with expanding US Equity exposure.
- βHealthy economics β 61% gross margin and 7% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About UPEXI INC
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates
UPEXI INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift UPXI price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
UPEXI INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.